Long-term safety of common ADHD medication for children and adolescents, global team finds. Long-term use of methylphenidate, the most commonly prescribed medication for treating ADHD, does not increase the risk of adverse developmental and psychiatric outcomes in children and adolescents, an international research team has found. The findings have led experts to argue for the drug’s inclusion on a global Essential Medicines list. Published in The Lancet Psychiatry, a controlled, longitudinal study has shown that methylphenidate – sold under brand names Ritalin, Concerta and others – treatment for children and adolescents over two years did not lead to adverse growth
Long-term safety confirmed for common ADHD medication as seen on The Hippocratic Post.